Tremblay J, Thibert L, Alarie I, Valiquette L, Pépin J. Nocardiosis in Quebec, Canada, 1988–2008. Clin Microbiol Infect. 2011;17:690–6.

Article  CAS  PubMed  Google Scholar 

Minero MV, Marín M, Cercenado E, Rabadán PM, Bouza E, Muñoz P. Nocardiosis at the turn of the century. Medicine. 2009;88:250–61.

Article  PubMed  Google Scholar 

Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. 2023. Mortality after nocardiosis: risk factors and evaluation of disseminated infection. Open Forum Infect Dis 10.

Takamatsu A, Yaguchi T, Tagashira Y, Watanabe A, Honda H. 2022. Nocardiosis in Japan: a Multicentric Retrospective Cohort Study. Antimicrob Agents Chemother 66.

Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc. 2012;87:403–7.

Article  PubMed  PubMed Central  Google Scholar 

Tashiro H, Takahashi K, Kusaba K, Tanaka M, Komiya K, Nakamura T, Aoki Y, Kimura S, Sueoka-Aragane N. Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis. Respir Investig. 2018;56:166–72.

Article  PubMed  Google Scholar 

Restrepo A, Clark NM. Nocardia infections in solid organ transplantation: guidelines from the infectious diseases Community of Practice of the American Society of Transplantation. Clin Transpl. 2019;33:1–12.

Article  Google Scholar 

Butler-Laporte G, Smyth E, Amar-Zifkin A, Cheng MP, McDonald EG, Lee TC. 2020. Low-dose TMP-SMX in the treatment of Pneumocystis Jirovecii Pneumonia: a systematic review and Meta-analysis. Open Forum Infect Dis 7.

Corsini Campioli C, Castillo Almeida NE, O’Horo JC, Challener D, Go JR, DeSimone DC, Sohail MR. 2021. Clinical presentation, management, and outcomes of patients with brain abscess due to Nocardia Species. Open Forum Infect Dis 8.

Ice LL, Barreto JN, Dao BD, Wolf RC, Dierkhising RA, Jannetto PJ, Langman LJ, Tosh PK. Relationship of Sulfamethoxazole Therapeutic Drug Monitoring to Clinical Efficacy and Toxicity. Ther Drug Monit. 2016;38:319–26.

Article  CAS  PubMed  Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377–81.

Article  Google Scholar 

Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.

Article  Google Scholar 

Mayo Clinic Laboratories. Sulfamethoxazole, Serum. https://www.mayocliniclabs.com/test-catalog/Overview/8238. Retrieved 8 February 2024.

Hall L, Doerr KA, Wohlfiel SL, Roberts GD. Evaluation of the MicroSeq System for Identification of Mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical Mycobacteriology Laboratory. J Clin Microbiol. 2003;41:1447–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL. 2016. Evaluation of Matrix-assisted laser desorption ionization-time of Flight Mass Spectrometry for Identification of Mycobacterium species, Nocardia species, and other Aerobic actinomycetes. J Clin Microbiol 54.

Blosser SJ, Drake SK, Andrasko JL, Henderson CM, Kamboj K, Antonara S, Mijares L, Conville P, Frank KM, Harrington SM, Balada-Llasat J-M, Zelazny AM. Multicenter Matrix-assisted laser desorption ionization–time of Flight Mass Spectrometry Study for Identification of clinically relevant Nocardia spp. J Clin Microbiol. 2016;54:1251–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cloud JL, Conville PS, Croft A, Harmsen D, Witebsky FG, Carroll KC. Evaluation of partial 16S ribosomal DNA sequencing for identification of Nocardia species by using the MicroSeq 500 system with an expanded database. J Clin Microbiol. 2004;42:578–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeoh K, Globan M, Naimo P, Williamson DA, Lea K, Bond K. 2022. Identification and antimicrobial susceptibility of referred Nocardia isolates in Victoria, Australia 2009–2019. J Med Microbiol 71.

CLSI. 2018. Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 3rd Edition. CLSI Guideline M24, 3rd ed. Wayne, PA.

CLSI. 2023. Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 2nd Edition. CLSI Supplement M24S.

Meng L, Mui E, Ha DR, Stave C, Deresinski SC, Holubar M. Comprehensive guidance for antibiotic dosing in obese adults: 2022 update. Pharmacotherapy: J Hum Pharmacol Drug Therapy. 2023;43:226–46.

Article  Google Scholar 

Pai MP. Drug Dosing based on Weight and Body Surface Area: Mathematical assumptions and limitations in obese adults. Pharmacotherapy: J Hum Pharmacol Drug Therapy. 2012;32:856–68.

Article  Google Scholar 

Kosaka M, Ushiki A, Ikuyama Y, Hirai K, Matsuo A, Hachiya T, Hanaoka M. 2017. A four-Center Retrospective Study of the efficacy and toxicity of low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis Pneumonia in patients without HIV infection. Antimicrob Agents Chemother 61.

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Gutiérrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS. New Creatinine- and cystatin C–Based equations to Estimate GFR without Race. N Engl J Med. 2021;385:1737–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083–107.

Article  PubMed  PubMed Central  Google Scholar 

Tritle BJ, Hejazi AA, Timbrook TT. 2021. The effectiveness and safety of low dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia: a systematic review and meta‐analysis. Transplant Infectious Disease 23.

Soueges S, Bouiller K, Botelho-Nevers E, Gagneux-Brunon A, Chirouze C, Rodriguez-Nava V, Dumitrescu O, Triffault-Fillit C, Conrad A, Lebeaux D, Hodille E, Valour F, Ader F. Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study. J Infect. 2022;85:130–6.

Article  CAS  PubMed  Google Scholar 

Tripodi MF, Durante-Mangoni E, Fortunato R, Cuccurullo S, Mikami Y, Farina C, Utili R. In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis. Transpl Infect Disease. 2011;13:335–43.

Article  CAS  Google Scholar 

Lebeaux D, Freund R, Van Delden C, Guillot H, Marbus SD, Matignon M, Van Wijngaerden E, Douvry B, De Greef J, Vuotto F, Tricot L, Fernández-Ruiz M, Dantal J, Hirzel C, Jais JP, Rodriguez-Nava V, Jacobs F, Lortholary O, Coussement J, Anstey JR, Antoine M, Ausselet N, Belhaj A, Boelens J, de Beenhouwer H, Denis C, Ho E, Ieven M, Jonckheere S, Knoop C, le Moine A, Rodriguez-Villalobos H, Racapé J, Roisin S, Vandercam B, Vander Zwalmen ML, Vanfraechem G, Van Laecke S, Verhaegen J, Barrou B, Battistella P, Bergeron E, Bouvier N, Caillard S, Caumes E, Chaussade H, Chauvet C, Crochette R, Epailly E, Essig M, Gallien S, Guillemain R, Herel C, Hoen B, Kamar N, le Gall T, Levi C, Lionet A, Longuet H, Guillemain R, Herel C, Hoen B, Kamar N, le Gall T, Levi C, Lionet A, Longuet H, Melica G, Miel A, Morel H, Ammar SO, Pattier S, Peraldi MN, Sayegh J, Scemla A, Senechal A, Tourret J, Boggian K, Egli A, Garzoni C, Hoffman M, Hirsch HH, Khanna N, Manuel O, Meylan P, Mueller NJ, Posfay-Barbe KM, Vu DL, Weisser M, Vollaard HM, Wunderink HF. 2017. Outcome and Treatment of Nocardiosis after Solid Organ Transplantation: New Insights from a European Study. Clinical Infectious Diseases 64:1396–1405.

Yetmar ZA, Wilson JW, Beam E. 2021. Recurrent nocardiosis in solid organ transplant recipients: an evaluation of secondary prophylaxis. Transpl Infect Disease 23.

Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. 2024. Epidemiology, timing, and secondary Prophylaxis of Recurrent Nocardiosis. Open Forum Infect Dis https://doi.org/10.1093/ofid/ofae122.